Jubilant Pharmova Share price

Q: How to buy Jubilant Pharmova Share at Choice?

To buy Jubilant Pharmova stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jubilant Pharmova, choose your preferred order type, and place the trade.

JUBLPHARMA

Healthcare Large Cap

964.45

7.50 (-0.77%)

NSE

BSE

Last updated on 10 Jun, 2026 | 15:31 IST

BuySell

Today's High

974.95

Today's Low

956.00

52 Week Low

786.05

52 Week High

1248.00

Jubilant Pharmova Chart

ChartIQ

TradingView

Jubilant Pharmova Share Key Metrics

Volume

55499.00

Market Cap

15361.87 CR

LTQ@LTP

29@964.45

ATP

964.27 Var Margin

17.15 %

Circuit Range

777.6-1166.3

Delivery %

46.58 %

Value

5.35 CR

ASM/GSM

No

Market Lot

1

Summary

Jubilant Pharmova share price is ₹964.45 as of 11 Jun, 2026. The stock Jubilant Pharmova intraday movement has stayed between ₹956.00 and ₹974.95, while on a 52-week basis,Jubilant Pharmova price 52 week high is ₹1248.00 & its 52 week low is ₹786.05.

In terms of trading activity, Jubilant Pharmova has recorded a volume of 55499 shares, The Jubilant Pharmova has a market cap of ₹159281139 CR. The stock’s Average Traded Price (ATP) stands at ₹964.27, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 29 @ ₹964.45.

Jubilant Pharmova operates within a circuit range of ₹777.60 – ₹1166.30, with a Value of ₹5.35 CR. The Delivery Percentage for the day is 46.58%. Additionally, Jubilant Pharmova currently falls under the No framework, and trades with a market lot size of 1.

Jubilant Pharmova Fundamentals

P/E Ratio

38.75

P/B Ratio

2.18

Div. Yield

0.52

Sector P/E

70.43

Sector P/B

3.01

Sec. Div. Yield

0.54

Jubilant Pharmova Resistance and Support

Pivot 968.87

Resistance

First Resistance

983.14

Second Resistance

994.32

Third Resistance

1008.59

Support

First Support

957.69

Second Support

943.42

Third Support

932.24

Jubilant Pharmova Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

50.68%

Mutual Fund

3.64%

Insurance

1.41%

Foreign Institutional Investors

16.96%

Domestic Institutional Investors

1.92%

Retail

25.39%

Others

0%

Total Promoters

MAR '24

50.68%

JUN '24

50.68%

SEP '24

50.68%

DEC '24

50.68%

Jubilant Pharmova Corporate Actions

Date	Agenda
2026-05-22	Audited Results & Final Dividend
2026-02-06	Quarterly Results
2025-10-31	Quarterly Results
2025-07-29	Quarterly Results
2025-05-16	Audited Results & Final Dividend
2025-01-31	Quarterly Results

Jubilant Pharmova News

Jubilant Pharmova Ltd - 530019 - USFDA Inspection Update - Contract Manufacturing Facility At Montreal, Canada

Jubilant Pharmova's subsidiary JHSGP received a USFDA Warning Letter for its contract manufacturing facility in Kirkland, Canada, following an inspection. The company has initiated corrective actions and continues operations under enhanced controls.

May 29 2026 21:10:17

Jubilant Pharmova Ltd - 530019 - Earnings Call Transcript

Jubilant Pharmova reported FY26 revenue of Rs.8,280 cr (up 14% YoY) and normalized PAT of Rs.442 cr (up 7% YoY). Management expects growth momentum to strengthen in FY27, with EBITDA margins improving in H2, driven by new product launches and operational efficiencies.

May 27 2026 20:24:53

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Jubilant Pharmova announced its Q4 and full year FY26 financial results, showing strong revenue growth across most business segments. The company highlighted strategic initiatives, including a new oncology product in CDMO and expansion of its PET manufacturing network.

May 22 2026 14:52:44

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Management

Jubilant Pharmova appointed Ashish Mukkirwar as its new Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) effective May 23, 2026. The previous CFO, Arun Kumar Sharma, moved to an advisory role.

May 22 2026 14:50:35

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Management

Jubilant Pharmova announced the appointment of Ashish Mukkirwar as Chief Financial Officer (CFO), effective May 23, 2026. He brings over two decades of financial leadership experience from companies like Glenmark Pharmaceuticals. Former CFO Arun Sharma will now serve as Advisor to the Chairmen.

May 22 2026 14:40:11

Jubilant Pharmova Ltd - 530019 - Record Date

Jubilant Pharmova has set July 24, 2026, as the record date for its final dividend. The dividend is ₹5.00 per equity share for FY26, subject to shareholder approval.

May 22 2026 14:33:03

Jubilant Pharmova Ltd - 530019 - Corporate Action-Board approves Dividend

Jubilant Pharmova recommends a final dividend of ₹5 per equity share for FY26. The record date for determining eligible shareholders is July 24, 2026.

May 22 2026 14:31:52

Jubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Outcome Of Meeting Held On May 22, 2026

Jubilant Pharmova approved its FY26 consolidated financial results, with revenue of ₹8,225 crore and net profit of ₹397.5 crore. The board recommended a final dividend of ₹5 per equity share for FY26, setting July 24, 2026, as the record date for payment.

May 22 2026 14:26:07

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Jubilant Pharmova will meet institutional investors and analysts on May 28, 2026, in Mumbai. The meetings will focus on discussing the Q4 FY26 earnings presentation and recently disclosed financial results, organized by 360 One Capital.

May 21 2026 18:56:19

Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Jubilant Pharmova has scheduled an analyst and institutional investor meeting on May 25, 2026. The meeting will focus on discussing the company's Q4 FY26 earnings performance, following the release of financial results and presentation.

May 18 2026 20:38:01

Name	Position
Naresh Kapoor	Company Secretary & Compliance Officer
Shyam S Bhartia	Chairman

Jubilant Pharmova Similar Stocks

Eris Lifesciences Ltd.

1366.90

-6.80 (0.50%)

Astrazeneca Pharma India Ltd.

8288.50

-164.50 (1.95%)

Cohance Lifesciences Ltd.

430.50

-1.40 (0.32%)

Caplin Point Laboratories Ltd.

2309.40

54.20 (2.40%)

Natco Pharma Ltd.

854.60

-10.40 (1.20%)

Alembic Pharmaceuticals Ltd.

737.20

5.70 (0.78%)

Dr. Agarwal's Health Care Ltd.

449.00

0.50 (0.11%)

Poly Medicure Ltd.

1417.50

-41.30 (2.83%)

Rainbow Children's Medicare Ltd.

1340.60

13.90 (1.05%)

Vijaya Diagnostic Centre Ltd.

1269.70

-26.50 (2.04%)

Jubilant Pharmova FAQs

The Buying Price of Jubilant Pharmova share is 964.45 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Jubilant Pharmova stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Jubilant Pharmova, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Jubilant Pharmova shares is 38.75. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Jubilant Pharmova shares is 2.18. Useful to assess the stock's value relative to its book value.

To assess Jubilant Pharmova’s valuation compare Sector P/E, P/B which are 70.43 & 3.01 with sector averages, along with growth rates and financial metrics.

The Market Cap of Jubilant Pharmova is 15361.87 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Jubilant Pharmova share price is 1248.00 & 786.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Jubilant Pharmova belongs to the Healthcare sector.